The Burdenko-GBM-Progression dataset contains imaging from 180 patients with primary glioblastoma treated at the Burdenko National Medical Research Center of Neurosurgery between 2014 and 2020. For each patient, the dataset includes imaging studies conducted for radiotherapy planning and follow-up studies. The radiotherapy studies consist of 4 MRI sequences (T1, T1C, T2, FLAIR), a topometric CT scan, and associated radiotherapy planning files (RTSTRUCT, RTPLAN, and RTDOSE). Follow-up studies (from 1 to 8-time per patient) include 2-4 MRI sequences (with a minimal set of T1C and FLAIR) per patient. Additional genetic information (IDH1/2, MGMT mutations) and treatment response status (tumour progression, tumour pseudoprogression, treatment response) are available for a subset of patients.
|